Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(4.03)
# 535
Out of 5,147 analysts
336
Total ratings
42.44%
Success rate
15.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $60.14 | +33.02% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $69.53 | +7.87% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $81.15 | -19.90% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $29.69 | -52.85% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $12.13 | +724.40% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $34.41 | +30.78% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $19.00 | +294.74% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $33.31 | -9.94% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $16.59 | +165.22% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $16.76 | -40.33% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $24.00 | -58.33% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.78 | +117.71% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.90 | +1,304.49% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $17.50 | -14.29% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.16 | +331.03% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.21 | -39.10% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $5.37 | -6.89% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $7.18 | +108.91% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $23.49 | +91.57% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.20 | +36.36% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.59 | +427.01% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.54 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.52 | +360.53% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $6.62 | -54.68% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.32 | -13.79% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.37 | +556.93% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.12 | +192.97% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $1,723,250 | $0.46 | +376,913,723.27% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.57 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $60.14
Upside: +33.02%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $69.53
Upside: +7.87%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $81.15
Upside: -19.90%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $29.69
Upside: -52.85%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $12.13
Upside: +724.40%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $34.41
Upside: +30.78%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $19.00
Upside: +294.74%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $33.31
Upside: -9.94%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $16.59
Upside: +165.22%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $16.76
Upside: -40.33%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $24.00
Upside: -58.33%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $13.78
Upside: +117.71%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.90
Upside: +1,304.49%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $17.50
Upside: -14.29%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.21
Upside: -39.10%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $5.37
Upside: -6.89%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $7.18
Upside: +108.91%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $23.49
Upside: +91.57%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.20
Upside: +36.36%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.59
Upside: +427.01%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.54
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.52
Upside: +360.53%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $6.62
Upside: -54.68%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.32
Upside: -13.79%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.37
Upside: +556.93%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.12
Upside: +192.97%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $1,723,250
Current: $0.46
Upside: +376,913,723.27%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.57
Upside: -